Us Bancorp \De\ Pfizer Inc Transaction History

Us Bancorp \De\

$71.8 Billion
Q1 2024

A detailed history of Us Bancorp \De\ transactions in Pfizer Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 6,670,981 shares of PFE stock, worth $187 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

6,670,981

Previous 7,157,655 6.8%

Holding current value

$187 Million

Previous $206 Million 10.17%

% of portfolio

0.26%

Previous 0.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$25.89 - $29.73 $12.6 Million - $14.5 Million	-486,674 Reduced 6.8%	6,670,981 $185 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $16 Million - $20.8 Million	-612,986 Reduced 7.89%	7,157,655 $206 Million
Q3 2023 Nov 03, 2023	SELL	$32.09 - $37.51 $6.05 Million - $7.07 Million	-188,422 Reduced 2.37%	7,770,641 $258 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $6.84 Million - $7.91 Million	-189,273 Reduced 2.32%	7,959,063 $292 Million
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $7.23 Million - $9.41 Million	-183,545 Reduced 2.2%	8,148,336 $332 Million

Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $34.7 Million - $45.3 Million	831,556 Added 11.09%	8,331,881 $427 Million
Q3 2022 Oct 27, 2022	SELL	$43.76 - $53.42 $7.41 Million - $9.05 Million	-169,442 Reduced 2.21%	7,500,325 $328 Million
Q2 2022 Aug 01, 2022	SELL	$46.53 - $55.17 $4.79 Million - $5.68 Million	-102,960 Reduced 1.32%	7,669,767 $402 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $11.2 Million - $13.9 Million	-245,805 Reduced 3.07%	7,772,727 $402 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $1.48 Million - $2.19 Million	35,782 Added 0.45%	8,018,532 $473 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $221,213 - $284,167	-5,636 Reduced 0.07%	7,982,750 $343 Million
Q2 2021 Aug 05, 2021	BUY	$35.91 - $40.68 $1.35 Million - $1.53 Million	37,570 Added 0.47%	7,988,386 $313 Million
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $5.29 Million - $5.97 Million	158,052 Added 2.03%	7,950,816 $288 Million
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $6.11 Million - $7.77 Million	182,465 Added 2.4%	7,792,764 $287 Million
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $9.12 Million - $10.7 Million	287,222 Added 3.92%	7,610,299 $279 Million
Q2 2020 Aug 07, 2020	BUY	$30.12 - $36.54 $9.69 Million - $11.8 Million	321,826 Added 4.6%	7,323,077 $239 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $6.09 Million - $8.7 Million	-225,319 Reduced 3.12%	7,001,251 $229 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $4.28 Million - $4.85 Million	-129,940 Reduced 1.77%	7,226,570 $283 Million
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $9.63 Million - $12.5 Million	-296,288 Reduced 3.87%	7,356,510 $264 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $3.13 Million - $3.52 Million	-84,728 Reduced 1.1%	7,652,798 $332 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $5.43 Million - $5.96 Million	-144,765 Reduced 1.84%	7,737,526 $329 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $5.4 Million - $6.16 Million	-140,363 Reduced 1.75%	7,882,291 $344 Million
Q3 2018 Nov 01, 2018	SELL	$34.47 - $41.81 $4.69 Million - $5.68 Million	-135,951 Reduced 1.67%	8,022,654 $354 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $8.56 Million - $9.12 Million	-259,483 Reduced 3.08%	8,158,605 $296 Million
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $5.31 Million - $6.16 Million	-166,317 Reduced 1.94%	8,418,088 $299 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $7.71 Million - $8.18 Million	-231,891 Reduced 2.63%	8,584,405 $311 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $273 Million - $301 Million	8,816,296	8,816,296 $315 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account